2022 American Transplant Congress
Impact of Dysgeusia on Transplant Recipients with Refractory Cytomegalovirus with/without Resistance Receiving Maribavir: Post-Hoc Analyses from a Phase 3 Randomized Trial
*Purpose: In a Phase 3 study (SOLSTICE; NCT02931539), maribavir (MBV) was superior to investigator-assigned therapies (IAT; val/ganciclovir, foscarnet, or cidofovir) for CMV clearance at Wk…2022 American Transplant Congress
International Practices on COVID-19 Vaccine Mandates for Transplant Candidates
*Purpose: The coronavirus disease 2019 (COVID-19) pandemic has created unprecedented challenges and there are practice differences for solid organ transplant programs worldwide. We sought to…2022 American Transplant Congress
Pretransplant microRNAs in Liver Perfusate Associate with Early Allograft Dysfunction
University of Maryland School of Medicine, Baltimore, MD
*Purpose: Early allograft dysfunction (EAD) in liver transplantation (LT) is associated with poor long-term graft and patient survival. Prior to LT, while organs are stored…2022 American Transplant Congress
Tuberculosis Screening Test Predicting Tuberculosis Infection in Solid Organ Transplant Recipients a Retrospective Cohort Study
*Purpose: Tuberculosis (TB) is a common infection that affects patients after solid organ transplantation (SOT). Thus, the American Society of transplantation (AST) recommends screening all…2022 American Transplant Congress
Factors Linked with Evaluation to Wait Listing for Referred Patients at the University of Texas Medical Branch’s Main Center and Outreach Clinic – A Step Towards Kidney Transplantation
*Purpose: Numerous factors can be associated with transplant candidates’ placement on the wait list. We herein set forth to assess patient characteristics and factors associated…2022 American Transplant Congress
High Dimensional Analysis of IL-10-Producing Human B Cells and Their Characterization in Operationally Tolerant Transplant Recipients
Stanford University Sch of Med, Stanford, CA
*Purpose: Regulatory B cells (Breg) participate in control of alloimmune responses in murine models of graft tolerance and are associated with improved outcomes in clinical…2022 American Transplant Congress
Post-Kidney Transplant Dementia Risk by Modifiable Risk Factors and CNIs Among Older Recipients
*Purpose: Up to 17% of older recipients develop dementia after kidney transplant (KT). While there are known modifiable risk factors for dementia among community-dwelling older…2022 American Transplant Congress
CD209+ Macrophages-Mediated Immunosuppressive Effects in ADPKD Tissues
*Purpose: The intensity of maintenance immunosuppression required in autosomal dominant polycystic kidney disease (ADPKD) patients after renal transplantation is lower than average, suggesting a reduced…2022 American Transplant Congress
Significant Improvements, but Consistent Disparities in Survival for African Americans After Liver Transplantation
Baylor College of Medicine, Houston, TX
*Purpose: Despite improvements in survival for all races in the past twenty years, African American patients have worse liver transplant outcomes after undergoing orthotopic liver…2022 American Transplant Congress
Trends in Donor Cause of Death and the Effect on Outcomes in Liver Transplantation Over 15-Years
*Purpose: Over the past 15 years, there has been a significant shift in donor cause of death (COD), which has coincided with an increase in…
- « Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 190
- Next Page »